Axsome Therapeutics
AXSM
AXSM
349 hedge funds and large institutions have $4.32B invested in Axsome Therapeutics in 2025 Q1 according to their latest regulatory filings, with 90 funds opening new positions, 102 increasing their positions, 114 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
9% more funds holding in top 10
Funds holding in top 10: 11 → 12 (+1)
0.85% less ownership
Funds ownership: 76.71% → 75.87% (-0.85%)
11% less repeat investments, than reductions
Existing positions increased: 102 | Existing positions reduced: 114
Holders
349
Holding in Top 10
12
Calls
$111M
Puts
$86.5M
Top Buyers
| 1 | +$72.7M | |
| 2 | +$61.5M | |
| 3 | +$45.1M | |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$42.4M |
| 5 |
Man Group
London,
United Kingdom
|
+$40.8M |
Top Sellers
| 1 | -$132M | |
| 2 | -$84.6M | |
| 3 | -$76.3M | |
| 4 |
Lazard Asset Management
New York
|
-$59.3M |
| 5 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$54.6M |